RACHEL DAY
Allopathic & Osteopathic Physicians|Dermatology CHAMBERSBURG, PA NPI 1033451679
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology PA REVANCE THERAPEUTICS, INC. All categories
General Payments — all program years on this page
$2,737.63
- Category: General Payments
- Program years: PY2018–2024
- Record count: 142
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $234.59 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $234.59 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $147.12 | 3 |
| Janssen Biotech, Inc. | $33.89 | 2 |
| LEO Pharma Inc. | $21.66 | 1 |
| GENZYME CORPORATION | $17.56 | 1 |
| Amgen Inc. | $14.36 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078556629 | Janssen Biotech, Inc. | $13.45 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078556721 | Janssen Biotech, Inc. | $20.44 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117537894 | Amgen Inc. | $14.36 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139880935 | GENZYME CORPORATION | $17.56 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147915941 | REVANCE THERAPEUTICS, INC. | $102.90 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147915943 | REVANCE THERAPEUTICS, INC. | $27.21 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147915945 | REVANCE THERAPEUTICS, INC. | $17.01 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152625683 | LEO Pharma Inc. | $21.66 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.